Download | < Back |
14 May 2015 | |
Alembic Pharmaceuticals Ltd has submitted to BSE a copy Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information pursuant to SEBI (Prohibition of Insider Trading) Regulation, 2015 as approved by the Board of Directors of the Company with effect from May 15, 2015. | |
View all announcements for ALEMBIC PHARMACEUTICALS LTD. | Source: BSE India |